1. US FDA. Written Requests Issued. https://www.fda.gov/drugs/development-resources/written-requests-issued. Accessed 25 Nov 2020.
2. US FDA. New Pediatric Labeling Information Database. https://www.accessdata.fda.gov/scripts/sda/sdNavigation.cfm?sd=labelingdatabase. Accessed 25 Nov 2020.
3. Mulugeta YL, Zajicek A, Barrett J, Sachs HC, McCune S, Sinha V, Yao L. Development of drug therapies for newborns and children: the scientific and regulatory imperatives. Pediatr Clin. 2017;64(6):1185–96.
4. EMA. Medicines https://www.ema.europa.eu/en/medicines/ema_group_types/ema_pip/field_ema_pip_decision_type%253Aname_field/P%3A%20decision%20agreeing%20on%20a%20investigation%20plan%2C%20with%20or%20without%20partial%20waiver%28s%29%20and%20or%20deferral%28s%29 Accessed 30 Sept 2020.
5. Tomasi P. Paediatric clinical trials: need for capacity building. J Clin Stud. 2013;5(3):10–6.